Trastuzumab infusion reactions in breast cancer. Should we routinely observe after the first dose?L Price, A M Brunt
16 March 2017
Periprocedural management of patients receiving novel oral anticoagulantsPaloma Arias Pou, Aquerreta González, Luis José Prieto Martínez, Amaya Delgado Latorre, María Serrano Alonso
23 February 2017
Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab)Jihyun Kim, Jihyun Chung, Sujin Park, Saem Jung, Dukwon Kang
13 January 2017
Rapid acting fentanyl formulations in breakthrough pain in cancer. Drug selection by means of the System of Objectified Judgement AnalysisRobert Janknegt, Marieke van den Beuken, Sjouke Schiere, Michael Überall, Roger Knaggs, Jaquie Hanley, Morten Thronaes
11 January 2017
Medication practice in hospitals: are nanosimilars evaluated and substituted correctly?Josefien Knoeff, Beat Flühmann, Stefan Mühlebach
23 January 2017
The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacistsPiotr Merks, Damian Swieczkowski, Michal Byliniak, Mariola Drozd, Katarzyna Krupa, Milosz Jaguszewski, David A Brindley, Bernard D Naughton
27 July 2016
Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rashNaoko Usui, Yoko Kondo, Noriko Ryota, Hidekazu Suzuki, Norio Okamoto, Masumi Sando, Eriko Tani, Masanari Hamaguchi, Ayako Tanaka, Motohiro Tamiya, Takayuki Shiroyama, Naoko Morishita, Emiko Tanaka, Tomonori Hirashima
3 August 2016
Value or cost: looking for the wider perspectivePhil Wiffen
22 February 2017
Deprescribing medicines in the acute setting to reduce the risk of fallsVanessa Marvin, Emily Ward, Alan J Poots, Katie Heard, Arvind Rajagopalan, Barry Jubraj
19 August 2016
Person-centred pharmaceutical care reduces emergency readmissionsJulia Blagburn, Ben Kelly-Fatemi, Nasima Akhter, Andy Husband
1 October 2015